Maddalena Veronesi, Arrigo FG Cicero, Maria Grazia Prandin, Ada Dormi, Eugenio Cosentino, Enrico Strocchi, and Claudio Borghi
A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice
Vasc Health Risk Manag. 2007 December; 3(6): 999–1005

V BARRIOS,1 C ESCOBAR,1 Á NAVARRO,2 L BARRIOS,1 J NAVARRO-CID,1 and A CALDERÓN1
Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: the LAURA Study
Int J Clin Pract. 2006 November; 60(11): 1364–1370

השוואה בין השפעת Lercanidipine ו-Ramipril על Albumin Excertion Rate בחולי סכרת מסוג 2 הסובלים מיתר לחץ דם ומיקרואלבומינריה   

Bang L.M., Chapman T.M., Goa K.L.
Lercanidipine: a review of its efficacy in the management of hypertension.
DRUGS 2003: 63 (22): 2449-2472

Messerli F.H.
Vasodilatory edema: a common side effect of antihypertensive therapy.
Current Cardiology Reports 2002; Vol. 4: 479-482

Leonetti G., Magnani B., Pessina AC, Rappelli A., Trimarco B., Zanchetti A.
Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives.
American Journal of Hypertension 2002; Vol. 15, No.11: 932-940

Messerli FH. And Grossman E.
Pedal- edema- not all dihydropyridine calcium antagonists are created equal
American Journal of Hypertension 2002; Vol. 15, No.11: 1019-1020

Fogari R., Mugellini A., Zoppi A., Corradi L., Rinaldi A., Derosa G., Preti P.
Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension.
American Journal of Hypertension 2003; 16(7): 596-9

Amenta F., Peleg E., Tomassoni D., Sabbatini M., Rosenthal T.
Effect of treatment with lercanidipine on heart of Cohen-Rosenthal diabetic hypertensive rats.
Hypertension 2003 ; 41(6): 1330-5

Massicotte J., Viens A., Yao MH., Leonardi A., Sironi G., Wang H., Dumont L.
Effects of lercanidipine on coronary reactivity and myocardial remodeling in transition to heart failure in cardiomyopathic hamsters.
Acta Pharmacologica Sinica 2003; 24(3): 199-206

Tomassoni D., Sabbatini M., Amenta F.
Effect of different dihydropyridine-type Ca2+ antagonists on left ventricle hypertrophy and coronary changes in spontaneously hypertensive rats.
Journal of Cardiovascular Pharmacology 2003; 41 (4), 544-552

Taddei S., Virdis A., Ghiadoni L., Versari D., Salvetti G., Magagna A., Salvetti A.
Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension.
Hypertension 2003; 41: 950-955

Cherubini A., Fabris F., Ferrari E., Cucinotta D., Antonelli Incalzi R., Senin U.
Comparative effects of lercanidipine, lacidipine, and nifedipine gastrointestinal therapeutic system on blood pressure and heart rate in elderly hypertensive patients: the ELderly and LErcanidipine (ELLE) study.
Archives of Gerontology and Geriatrics 2003; 37:203-212.

Romito R., Pansini M.I.,Perticone F., Antonelli G., Pitzalis M., Rizzon P.
Comparative effect of lercanidipine, felodipine, and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hypertension: the LErcanidipine in ADults (LEAD) study.
Journal of Clinical Hypertension 2003; 5(4):249-53.

Acanfora D., Trojano L., Gheorghiade M., Picone C., Papa A., Furgi G., Giuliano F., Maestri R., Rengo F.
A randomised, double-blind comparison of 10 and 20 mg lercanidipine in patients with stable effort angina; effects on myocardial ischemia and heart rate variablity"
American Journal of Therapeutics 2002; 9: 444-453.

James IGV, Jones A, Davies P
A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension.
Journal of Human Hypertension 2002; 16, 605-610

Viviani GL
Lercanidipine in type II diabetic patients with mild to moderate arterial hypertension.
Journal Cardiovascular Pharmacology 2002; 40(1): 133-9

Robles NR, Vilatoro J., Pastor L., Manjon M., Ocon J., Gomez Campdera F.
Lercanidipie in chronic renal failure.
Journal of Hypertension 2002, Vol. 20(suppl. 4), S391

Kalus JS, White CM
Lercanidipine: a long-acting dihydropyridine calcium channel blocker for treatment of hypertension.
Formulary 2002; Vol.37(5), 234-238

Barrios V., Carrasco J.L., Esteras A., Herranz I., Luque M., Navarro A., Navarro-Cid J., Prieto L., Romero J., Ruilope L.M., Tamargo J.
Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE study.
Blood Pressure 2002; Vol. 11, 95-100

Fogari R., Corradi L., Mugellini A., Preti P.
Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension.
American J. Hypertension Vol. 15, (4) (Part 2/2), pg. 36/A (2002)

Seravalle G., Stella M.L., Grassi G., Mancia G. 
Comparative effects of lercanidipine and hydrochlorothiazide on hypertension-related cardiac and vascular structural alterations.
American J. Hypertension Vol. 15, (4) (Part 2/2), pg. 39/A (2002)

Epstein M.
Lercanidipine: A novel dihydropyridine calcium- channel blocker
Journal of Heart Disease, 2001, Vol. 3: 398-407

Venkata C.S. Ram
Usefulness of lercanidipine, a new calcium antagonist, for systemic hypertension.
The American Journal of Cardiology, 2002, Vol. 89, pg. 214-15

Amenta F., Leonardi A., Sabbatini M., Testa R., Tomassoni D., Vitaioli L.
Effects of dihydropyridine-type Ca2+ antagonists on the renal arterial tree in spontaneously hypertensive rats.
Journal Cardiovascular Pharmacology 2002; Vol.39(1), 39-48

 Lamberto A. De Giorgio., Orlandini F., Malasoma P., Zappa A.
Double blind, crossover study of Lercanidipine versus amlodipine in the treatment of mild-to-moderate essential hypertension.
Current Therapeutic Research, 1999, Vol. 60: 511-520